MMP-3 Inhibitor

CAS No. 158841-76-0

MMP-3 Inhibitor( —— )

Catalog No. M34905 CAS No. 158841-76-0

MMP-3 Inhibitor is a peptide matrix metalloproteinase-3 (MMP-3) inhibitor with a Ki value of 95 nM.MMP-3 inhibitor has anticancer and antitumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 221 In Stock
5MG 208 In Stock
10MG 310 In Stock
25MG 525 In Stock
50MG 741 In Stock
100MG 1014 In Stock
200MG Get Quote In Stock
500MG 2065 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MMP-3 Inhibitor
  • Note
    Research use only, not for human use.
  • Brief Description
    MMP-3 Inhibitor is a peptide matrix metalloproteinase-3 (MMP-3) inhibitor with a Ki value of 95 nM.MMP-3 inhibitor has anticancer and antitumor activity.
  • Description
    MMP3 inhibitor 3 is an inhibitor of MMP3. MMP3 inhibitor 3 can used to study breast cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MMP
  • Recptor
    MMP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    158841-76-0
  • Formula Weight
    686.78
  • Molecular Formula
    C27H46N10O9S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C([C@@H](NC(CNC([C@@H](NC([C@H](CCCNC(=N)N)NC(C)=O)=O)CS)=O)=O)[C@H](C)C)(=O)N1[C@H](C(N[C@@H](CC(O)=O)C(N)=O)=O)CCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Holliday DL, et al. Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion. Breast Cancer Res. 2007;9(5):R67.?
molnova catalog
related products
  • TAPI 0

    ADAM-17 (TACE) and MMP inhibitor; attenuates TNF-α processing. Acts in concert with GM6001 to inhibit Chlamydia trachomatis growth.

  • S-methyl-KE-298

    S-methyl-KE-298 is the second main metabolite in plasma,is a methyl conjugate of deacetyl-KE-298.KE-298 inhibits matrix metalloproteinase (MMP-1) production from ?rheumatoid arthritis (RA) synovial cells.

  • NSC 405020

    NSC 405020 is a noncatalytic inhibitor of MT1-MMP, directly interacts with PEX domain of MT1-MMP, affects PEX homodimerization but not catalytic activity of MT1-MMP.